Ribox 120 mg is an oral non-steroidal anti-inflammatory drug (NSAID) designed for the management of pain, inflammation, and related symptoms in various musculoskeletal and inflammatory disorders. It is a selective cyclooxygenase-2 (COX-2) inhibitor, offering anti-inflammatory, analgesic, and antipyretic effects with a reduced risk of gastrointestinal toxicity compared to non-selective NSAIDs.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
COX-2 Selective Inhibitor
Ribox 120 mg is indicated for symptomatic relief and management of conditions associated with pain and inflammation, including:
Osteoarthritis (OA): Relieves joint pain, stiffness, and inflammation.
Rheumatoid Arthritis (RA): Reduces pain, swelling, and inflammation in joints.
Ankylosing Spondylitis: Helps manage chronic spinal inflammation and stiffness.
Acute Gouty Arthritis: Eases pain and inflammation during flare-ups.
Dental Surgery Pain: Provides short-term relief of moderate post-operative pain.
Ribox 120 mg selectively inhibits COX-2, the enzyme primarily responsible for producing prostanoids that mediate pain, inflammation, and fever. Unlike non-selective NSAIDs, Ribox has minimal inhibition of COX-1, reducing gastrointestinal adverse effects and avoiding significant effects on platelet aggregation.
Analgesic: Reduces pain by lowering prostaglandin synthesis at sites of inflammation.
Anti-inflammatory: Alleviates swelling and joint stiffness by targeting inflammatory pathways.
Antipyretic: Lowers fever through central and peripheral prostaglandin suppression.
Adults and Adolescents (≥16 years):
Osteoarthritis: 30 mg once daily, may increase to 60 mg if needed.
Rheumatoid Arthritis / Ankylosing Spondylitis: 90 mg once daily.
Acute Gouty Arthritis: 120 mg once daily (typically up to 8 days).
Postoperative Dental Pain: 90 mg once daily for up to 3 days.
Administration: Oral, with or without food. Use the lowest effective dose for the shortest duration to minimize cardiovascular and gastrointestinal risks.
Oral anticoagulants (e.g., warfarin): May increase prothrombin time; monitor closely.
Diuretics, ACE inhibitors, ARBs: NSAIDs may reduce antihypertensive efficacy.
Aspirin: Low-dose aspirin may be co-administered for cardiovascular prophylaxis.
Ciclosporin / Tacrolimus: Increased risk of nephrotoxicity.
Lithium: May increase plasma lithium levels.
Hypersensitivity to Ribox or excipients
Active peptic ulcer or GI bleeding
Severe hepatic or renal impairment
Children <16 years
Pregnancy and lactation
History of cardiovascular disease, uncontrolled hypertension, or congestive heart failure
Inflammatory bowel disease
Common and less common adverse effects include:
Palpitations, fatigue, dizziness, nausea, and diarrhea
Influenza-like symptoms, flushing, dry mouth
Rare: Confusion, hallucinations, atrial fibrillation, transient ischemic attack
Gastrointestinal Risk: Elderly and patients with history of ulcers should use caution.
Cardiovascular Risk: Monitor patients with hypertension, hyperlipidemia, diabetes, or prior cardiac events.
Renal & Hepatic Monitoring: Assess function periodically, especially in patients with pre-existing conditions.
Hypersensitivity: Discontinue at first sign of rash or mucosal lesions.
Pregnancy: Avoid, especially in the third trimester due to risk of premature ductus arteriosus closure.
Lactation: Not recommended; Ribox is excreted in breast milk.
Supportive therapy is recommended.
Single doses up to 500 mg and repeated doses up to 150 mg/day for 21 days have not shown significant toxicity.
Store below 30°C, protected from light and moisture.
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet